Why is Prenetics stock rallying today?

Prenetics stock surged 3.3% in pre-market trading following the release of its Q2 FY2026 financial results, which exceeded expectations with a revenue of $46.5 million, nearly tripling compared to the same period last year. The standout performer, IM8 wellness brand, generated $45.0 million in revenue, marking a remarkable 359% year-over-year increase and the brand's sixth consecutive record quarter.

Additionally, the company reported that July was the strongest month in IM8's history, with $20.9 million in revenue, and announced positive Adjusted Free Cash Flow for the first time, a milestone CEO Danny Yeung highlighted as crucial for the brand's growth. Furthermore, Prenetics raised its full-year 2026 total revenue guidance to $220–$230 million and set an ambitious FY2027 IM8 revenue target of $400 million or more, assuming no contribution from upcoming product launches.

This positive earnings beat, coupled with the cash flow inflection point and aggressive forward guidance, provided investors with multiple reasons to bid the stock higher, driving it towards $20.01 and near its 52-week high of $23.63, despite the broader market's negative trend.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.